PRA Health Sciences (PRAH) Tops Q3 EPS by 7c; Lifts FY15 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Avondale Partners Downgrades PRA Health Sciences (PRAH) to Underperform
November 4, 2015 7:59 AM ESTAvondale Partners downgraded PRA Health Sciences (NASDAQ: PRAH) from Market Perform to Underperform with a price target of $31.50.
For an analyst ratings summary and ratings history on PRA Health Sciences click here. For more ratings news on PRA Health Sciences click here.
Shares of PRA Health Sciences closed at $41.31 yesterday.
... More


